Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-26 @ 2:05 AM
NCT ID:
NCT02039505
Group ID:
EG004
Title:
Maintenance Phase: Vedolizumab 300 mg
Description:
Vedolizumab 300 mg, IV infusion, once at Weeks 14, 22, 30, 38, 46 and 54 in maintenance phase. Participants received vedolizumab in induction phase and achieved clinical response at Week 10 and were randomized to receive vedolizumab in maintenance phase.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
41
Other Number Affected:
27
Other Number At Risk:
41
Study:
NCT02039505
Results Section:
NCT02039505
Adverse Events Module:
NCT02039505